XML 18 R11.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value Measurement
9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurement

Note 3. Fair Value Measurement

 

The Company measures and reports certain financial instruments as assets and liabilities at fair value on a recurring basis. The following tables set forth the fair value of the Company’s financial assets, which consist of cash equivalents and marketable securities measured and recognized at fair value (in thousands):

 

 

 

 

 

September 30, 2024

 

 

 

Fair Value
Hierarchy
Level

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair
Value

 

Financial assets included in cash and cash
   equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

Level 1

 

$

84,259

 

 

$

 

 

$

 

 

$

84,259

 

Total

 

 

 

$

84,259

 

 

$

 

 

$

 

 

$

84,259

 

 

 

 

 

 

December 31, 2023

 

 

 

Fair Value
Hierarchy
Level

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair
Value

 

Financial assets included in cash and cash
   equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

Level 1

 

$

174,429

 

 

$

 

 

$

 

 

$

174,429

 

Total

 

 

 

$

174,429

 

 

$

 

 

$

 

 

$

174,429

 

 

The Company evaluates transfers between levels at the end of each reporting period. There were no transfers between Levels 1, 2 and 3 during the three and nine months ended September 30, 2024 and 2023. As of September 30, 2024 and December 31, 2023, there were no financial instruments classified as Level 2 or Level 3. There have been no realized gains or losses recognized for the periods presented. Unrealized gains and losses are included in accumulated other comprehensive loss within stockholders' equity on the balance sheet.

There were no investments as of September 30, 2024 and December 31, 2023, as such, no allowance for credit losses has been recognized as of September 30, 2024. During the three and nine months ended September 30, 2024 and 2023, the Company did not recognize any impairment losses related to investments.